These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 35532150)
1. PLGA sustained-release microspheres loaded with an insoluble small-molecule drug: microfluidic-based preparation, optimization, characterization, and evaluation Su Y; Liu J; Tan S; Liu W; Wang R; Chen C Drug Deliv; 2022 Dec; 29(1):1437-1446. PubMed ID: 35532150 [TBL] [Abstract][Full Text] [Related]
2. Three months extended-release microspheres prepared by multi-microchannel microfluidics in beagle dog models. Kim JH; Ryu CH; Chon CH; Kim S; Lee S; Maharjan R; Kim NA; Jeong SH Int J Pharm; 2021 Oct; 608():121039. PubMed ID: 34450228 [TBL] [Abstract][Full Text] [Related]
3. Microfluidic preparation of PLGA microspheres as cell carriers with sustainable Rapa release. Zhu C; Yang H; Shen L; Zheng Z; Zhao S; Li Q; Yu F; Cen L J Biomater Sci Polym Ed; 2019; 30(9):737-755. PubMed ID: 30935290 [TBL] [Abstract][Full Text] [Related]
4. Injectable testosterone PLGA microsphere with different characteristics: effect of preparation method (paddle mixing versus microfluidic device). Oe Y; Kobayashi M; Yoshida T; Kojima H; Terukina T; Kondo H Pharm Dev Technol; 2024 Jun; 29(5):482-491. PubMed ID: 38682665 [TBL] [Abstract][Full Text] [Related]
5. Microfluidic-based fabrication and characterization of drug-loaded PLGA magnetic microspheres with tunable shell thickness. He C; Zeng W; Su Y; Sun R; Xiao Y; Zhang B; Liu W; Wang R; Zhang X; Chen C Drug Deliv; 2021 Dec; 28(1):692-699. PubMed ID: 33818236 [TBL] [Abstract][Full Text] [Related]
6. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist. Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531 [TBL] [Abstract][Full Text] [Related]
7. The Modified Exenatide Microspheres: PLGA-PEG-PLGA Gel and Zinc-Exenatide Complex Synergistically Reduce Burst Release and Shorten Platform Stage. Jiang W; Gao X; Wang Q; Chen Y; Li D; Zhang X; Yang X AAPS PharmSciTech; 2023 Nov; 24(8):251. PubMed ID: 38036924 [TBL] [Abstract][Full Text] [Related]
8. Long-term sustained release Poly(lactic-co-glycolic acid) microspheres of asenapine maleate with improved bioavailability for chronic neuropsychiatric diseases. Zhai J; Wang YE; Zhou X; Ma Y; Guan S Drug Deliv; 2020 Dec; 27(1):1283-1291. PubMed ID: 32885707 [TBL] [Abstract][Full Text] [Related]
9. Microfluidic preparation of monodisperse PLGA-PEG/PLGA microspheres with controllable morphology for drug release. Chen W; Li H; Zhang X; Sang Y; Nie Z Lab Chip; 2024 Sep; 24(19):4623-4631. PubMed ID: 39248189 [TBL] [Abstract][Full Text] [Related]
10. In vitro drug release and antibacterial activity evaluation of silk fibroin coated vancomycin hydrochloride loaded poly (lactic-co-glycolic acid) (PLGA) sustained release microspheres. Li S; Shi X; Xu B; Wang J; Li P; Wang X; Lou J; Li Z; Yang C; Li S; Zhen P J Biomater Appl; 2022 Apr; 36(9):1676-1688. PubMed ID: 35015589 [TBL] [Abstract][Full Text] [Related]
11. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres. Jiang G; Qiu W; DeLuca PP Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968 [TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization, and pharmacodynamics of exenatide-loaded poly(DL-lactic-co-glycolic acid) microspheres. Liu B; Dong Q; Wang M; Shi L; Wu Y; Yu X; Shi Y; Shan Y; Jiang C; Zhang X; Gu T; Chen Y; Kong W Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1474-9. PubMed ID: 21048339 [TBL] [Abstract][Full Text] [Related]
13. [Preparation of aspirin sustained-release microsphere and its in vitro releasing property]. Chen Y; Liu ZN; Li B; Jiang T Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Oct; 51(5):907-912. PubMed ID: 31624397 [TBL] [Abstract][Full Text] [Related]
14. Exenatide-loaded inside-porous poly(lactic-co-glycolic acid) microspheres as a long-acting drug delivery system with improved release characteristics. Zhai J; Ou Z; Zhong L; Wang YE; Cao LP; Guan S Drug Deliv; 2020 Nov; 27(1):1667-1675. PubMed ID: 33241694 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Woo BH; Jiang G; Jo YW; DeLuca PP Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769 [TBL] [Abstract][Full Text] [Related]
16. Sophoridine-loaded PLGA microspheres for lung targeting: preparation, in vitro, and in vivo evaluation. Wang W; Cai Y; Zhang G; Liu Y; Sui H; Park K; Wang H Drug Deliv; 2016 Nov; 23(9):3674-3680. PubMed ID: 27689622 [TBL] [Abstract][Full Text] [Related]
17. Development of a sustained-release system for perivascular delivery of dipyridamole. Zhu W; Masaki T; Bae YH; Rathi R; Cheung AK; Kern SE J Biomed Mater Res B Appl Biomater; 2006 Apr; 77(1):135-43. PubMed ID: 16206204 [TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA. Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP Pharm Res; 1999 Apr; 16(4):509-13. PubMed ID: 10227704 [TBL] [Abstract][Full Text] [Related]
19. Preparation of glucagon-like peptide-1 loaded PLGA microspheres: characterizations, release studies and bioactivities in vitro/in vivo. Yin D; Lu Y; Zhang H; Zhang G; Zou H; Sun D; Zhong Y Chem Pharm Bull (Tokyo); 2008 Feb; 56(2):156-61. PubMed ID: 18239299 [TBL] [Abstract][Full Text] [Related]
20. Sustained delivery of vascular endothelial growth factor using a dextran/poly(lactic-co-glycolic acid)-combined microsphere system for therapeutic neovascularization. Zhang ZD; Xu YQ; Chen F; Luo JF; Liu CD Heart Vessels; 2019 Jan; 34(1):167-176. PubMed ID: 30043157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]